As of 2026-03-22, the Relative Valuation of Neurocrine Biosciences Inc (NBIX) is 75.12 USD. This relative valuation is based on P/E multiples. With the latest stock price at 127.68 USD, the upside of Neurocrine Biosciences Inc based on Relative Valuation is -41.2%.
The range of the Relative Valuation is 43.49 - 121.07 USD.
| Range | Selected | |
| Trailing P/E multiples | 9.1x - 18.9x | 11.4x |
| Forward P/E multiples | 12.0x - 22.6x | 17.8x |
| Fair Price | 43.49 - 121.07 | 75.12 |
| Upside | -65.9% - -5.2% | -41.2% |
| Date | P/E |
| 2026-03-20 | 26.77 |
| 2026-03-19 | 27.20 |
| 2026-03-18 | 27.41 |
| 2026-03-17 | 27.41 |
| 2026-03-16 | 27.23 |
| 2026-03-13 | 27.21 |
| 2026-03-12 | 26.79 |
| 2026-03-11 | 27.16 |
| 2026-03-10 | 27.23 |
| 2026-03-09 | 27.25 |
| 2026-03-06 | 26.87 |
| 2026-03-05 | 27.18 |
| 2026-03-04 | 27.98 |
| 2026-03-03 | 27.50 |
| 2026-03-02 | 27.76 |
| 2026-02-27 | 27.73 |
| 2026-02-26 | 27.39 |
| 2026-02-25 | 27.50 |
| 2026-02-24 | 27.46 |
| 2026-02-23 | 26.92 |
| 2026-02-20 | 26.97 |
| 2026-02-19 | 27.28 |
| 2026-02-18 | 26.92 |
| 2026-02-17 | 26.79 |
| 2026-02-13 | 26.03 |
| 2026-02-12 | 25.81 |
| 2026-02-11 | 28.82 |
| 2026-02-10 | 28.86 |
| 2026-02-09 | 29.27 |
| 2026-02-06 | 29.61 |
| 2026-02-05 | 28.92 |
| 2026-02-04 | 28.91 |
| 2026-02-03 | 29.14 |
| 2026-02-02 | 28.86 |
| 2026-01-30 | 28.53 |
| 2026-01-29 | 28.93 |
| 2026-01-28 | 28.24 |
| 2026-01-27 | 28.08 |
| 2026-01-26 | 28.21 |
| 2026-01-23 | 28.56 |
| 2026-01-22 | 28.81 |
| 2026-01-21 | 28.39 |
| 2026-01-20 | 28.21 |
| 2026-01-16 | 27.76 |
| 2026-01-15 | 27.96 |
| 2026-01-14 | 28.38 |
| 2026-01-13 | 27.73 |
| 2026-01-12 | 27.82 |
| 2026-01-09 | 28.47 |
| 2026-01-08 | 28.43 |